Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Webcast of a CCO symposium at CHEST 2019 featuring expert perspectives on optimal integration of immunotherapy into stage III NSCLC care using a multidisciplinary approach
In this slideset, a multidisciplinary expert panel reviews the latest clinical data supporting the optimal use of checkpoint inhibitor therapy for stage III NSCLC.
In this slideset, a multidisciplinary expert panel provides insights on optimal use of checkpoint inhibition in the treatment of a series of patient cases with stage III NSCLC.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.